2018
DOI: 10.2147/ijn.s174300
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation of chloroquine and doxorubicin by MPEG-PLA to enhance anticancer effects by lysosomes inhibition in ovarian cancer

Abstract: PurposeAs the deadliest gynecological malignancy, ovarian cancer ranks as a major cause of disease-related deaths to women worldwide and is treated with transurethral resection or systemic chemotherapy. However, traditional chemotherapeutic drug in antitumor therapy has shown unavoidable limitations, such as poor curative effects, systemic toxicity and development of drug resistance, leading to failure of tumor inhibition and recurrence. This study aims to explore an innovative method to enhance the clinical e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 28 publications
1
21
1
Order By: Relevance
“…Lysosome is the intracellular target of some nanomaterials and its permeabilization is involved in material-mediated cell death [35]. Inhibiting lysosome function enhances the antitumor activity of chemotherapeutic drugs and increases the sensitivity of tumors to radiotherapy [36,37]. We employed the acridine orange (AO) dye to stain 4T1 cells.…”
Section: Antitumor Evaluation In Vitromentioning
confidence: 99%
“…Lysosome is the intracellular target of some nanomaterials and its permeabilization is involved in material-mediated cell death [35]. Inhibiting lysosome function enhances the antitumor activity of chemotherapeutic drugs and increases the sensitivity of tumors to radiotherapy [36,37]. We employed the acridine orange (AO) dye to stain 4T1 cells.…”
Section: Antitumor Evaluation In Vitromentioning
confidence: 99%
“…Many multifaceted merits are realized in PLA and PLGA based DDS such as sustainment of drug release, targeted delivery, improving the bioavailability, and enhancement of the stability of encapsulated biopharmaceuticals towards enzymatic degradation (Moghimi et al 2001;Mundargi et al 2008). With great effort, in the last years, different PLA and PLGA based drugs delivery systems have been developed, in particular for the delivery of anticancer drugs (Haggag et al 2019;Jain et al 2011Jain et al , 2016Shao et al 2018) and for a specific organ targeting such as brain or liver targeting (Bao et al 2015;Gao et al 2015;Jose et al 2014;Patel et al 2018;Xia et al 2012;Zhu et al 2016). Moreover, these delivery systems have been tested with great results for pulmonary administration of different drugs (Feng et al 2014;Gaspar et al 2019;Takami and Murakami 2011).…”
Section: Introductionmentioning
confidence: 99%
“…An equivalent volume of solvent corresponding to each drug was used as a vehicle control. The drug dosage and methods of delivery were determined by literature data and preliminary experiments [27,[49][50][51][52][53]. All drug solutions were freshly prepared on the day of use.…”
Section: Drug Administrationmentioning
confidence: 99%